Spatomics

BiotechnologyAngelNanjing, China

Latest round

Angel

Last raised

Aug 2023

Total raised

Undisclosed

Investors

3

About Spatomics

, trading as Spatomics, is a healthcare company focusing on the development of single-cell spatial multi-omics tool platforms. It has commercial collaborations with several spatial histology CROs, reagent companies, etc. The founder and CEO, Rui Zheng, worked at Thermo Fisher and the total revenue of the products he developed has exceeded USD 1 billion. Five members of the company's team hold doctoral degrees. The company is committed to building a core tool platform for single-cell spatial multi-omics. The single-cell spatial multi-omics instrument developed by the company is capable of completing tissue section pre-processing, antigen repair, staining, imaging, and image pre-processing. In terms of performance, it contains the advantages of high sensitivity and high throughput. The company's revenue is generated by providing end-to-end universal solution for single-cell spatial multi-omics.

Who invested in Spatomics

3 investors across 1 round

See all investors in Spatomics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Aug 9, 2023

    Amount

    Undisclosed

    Investors

    Locked

Questions about Spatomics

Who invested in Spatomics?

Spatomics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Spatomics raised?

Spatomics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Spatomics last raise money?

Spatomics's most recent round on record is a Angel, in Aug 2023.

What does Spatomics do?

, trading as Spatomics, is a healthcare company focusing on the development of single-cell spatial multi-omics tool platforms.

Where is Spatomics headquartered?

Spatomics is headquartered in Nanjing, China.

Which VCs invest in companies like Spatomics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Spatomics's stage. Their profiles are linked below.

Raising like Spatomics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.